EL USO DE UNA COMPOSICION DE CELECOXIB PARA EL ALIVIO RAPIDO DEL DOLOR
SE REFIERE AL USO DE CELECOXIB POR VIA ORAL UTILIZANDOSE DE 50mg A 400mg; EN AYUNAS PROPORCIONA UNA CONCENTRACION EN EL PLASMA DE AL MENOS 250 ng/ml A MAS TARDAR 30 MINUTOS DESPUES DE LA ADMINISTRACION O EXHIBE UN Tmax NO MAYOR DE 1.25 HORAS; EL CELECOXIB SE FORMULA COMO UNA DISPERSION ULTRA FINA O...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | GAO PING FORBES JAMES C HASSAN FRED KARIM AZIZ BRUGGER ANDREW M |
| description | SE REFIERE AL USO DE CELECOXIB POR VIA ORAL UTILIZANDOSE DE 50mg A 400mg; EN AYUNAS PROPORCIONA UNA CONCENTRACION EN EL PLASMA DE AL MENOS 250 ng/ml A MAS TARDAR 30 MINUTOS DESPUES DE LA ADMINISTRACION O EXHIBE UN Tmax NO MAYOR DE 1.25 HORAS; EL CELECOXIB SE FORMULA COMO UNA DISPERSION ULTRA FINA O SOLUCION EN UN MEDIO LIQUIDO O SE FORMULA COMO PARTICULAS SOLIDAS QUE TIENEN UN TAMANO D90 MENOR DE 10µm; O SE FORMULA DISOLVIENDOLO EN UN SOLVENTE ADECUADO Y AGREGANDO LA SOLUCION RESULTANTE A UN LIQUIDO ACUOSO (POLIETILENGLICOL) PARA FORMAR UNA SUSPENSION FINA QUE SE ADMINISTRA AL INDIVIDUO A MAS TARDAR 15 MINUTOS DESPUES DE LA PREPARACION. LA FORMULACION SE ENCAPSULA CON UNA PARED QUE COMPRENDE GELATINA, HIDROXIPROPILMETILCELULOSA. TAMBIEN SE REFIERE AL USO EN COMBINACION CON CODEINA, MEPERIDINA, MORFINA, CAFEINA, TEOFILINA, TEOBROMINA.
There is provided a method of rapidly relieving pain in a mammalian, preferably human, subject. The method comprises orally administering to the subject an effective pain-relieving amount of a composition comprising celecoxib formulated in such a way as to provide, when tested in fasting humans in accordance with standard pharmacokinetic practice, a blood plasma concentration profile of celecoxib in which a concentration of about 250 ng/ml is attained not later than about 30 minutes after oral administration. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PE20011326A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PE20011326A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PE20011326A13</originalsourceid><addsrcrecordid>eNrjZHBz9VEIDfZXcHFVCPVzVHD29w3wD_Z09vT3Awk5u_q4OvtHeDopBDgGOSoA1Tr6eIZ5-isEOQZ4uoB0-Si4-Pv4B_EwsKYl5hSn8kJpbgZFN9cQZw_d1IL8-NTigsTk1LzUkvgAVyMDA0NDYyMzR0NjYtQAAEt8K3E</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>EL USO DE UNA COMPOSICION DE CELECOXIB PARA EL ALIVIO RAPIDO DEL DOLOR</title><source>esp@cenet</source><creator>GAO PING ; FORBES JAMES C ; HASSAN FRED ; KARIM AZIZ ; BRUGGER ANDREW M</creator><creatorcontrib>GAO PING ; FORBES JAMES C ; HASSAN FRED ; KARIM AZIZ ; BRUGGER ANDREW M</creatorcontrib><description>SE REFIERE AL USO DE CELECOXIB POR VIA ORAL UTILIZANDOSE DE 50mg A 400mg; EN AYUNAS PROPORCIONA UNA CONCENTRACION EN EL PLASMA DE AL MENOS 250 ng/ml A MAS TARDAR 30 MINUTOS DESPUES DE LA ADMINISTRACION O EXHIBE UN Tmax NO MAYOR DE 1.25 HORAS; EL CELECOXIB SE FORMULA COMO UNA DISPERSION ULTRA FINA O SOLUCION EN UN MEDIO LIQUIDO O SE FORMULA COMO PARTICULAS SOLIDAS QUE TIENEN UN TAMANO D90 MENOR DE 10µm; O SE FORMULA DISOLVIENDOLO EN UN SOLVENTE ADECUADO Y AGREGANDO LA SOLUCION RESULTANTE A UN LIQUIDO ACUOSO (POLIETILENGLICOL) PARA FORMAR UNA SUSPENSION FINA QUE SE ADMINISTRA AL INDIVIDUO A MAS TARDAR 15 MINUTOS DESPUES DE LA PREPARACION. LA FORMULACION SE ENCAPSULA CON UNA PARED QUE COMPRENDE GELATINA, HIDROXIPROPILMETILCELULOSA. TAMBIEN SE REFIERE AL USO EN COMBINACION CON CODEINA, MEPERIDINA, MORFINA, CAFEINA, TEOFILINA, TEOBROMINA.
There is provided a method of rapidly relieving pain in a mammalian, preferably human, subject. The method comprises orally administering to the subject an effective pain-relieving amount of a composition comprising celecoxib formulated in such a way as to provide, when tested in fasting humans in accordance with standard pharmacokinetic practice, a blood plasma concentration profile of celecoxib in which a concentration of about 250 ng/ml is attained not later than about 30 minutes after oral administration.</description><edition>7</edition><language>spa</language><subject>BABY COMFORTERS ; CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICALPURPOSES ; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY ; DEVICES FOR RECEIVING SPITTLE ; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGINGPHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL ORADMINISTERING FORMS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2002</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20020206&DB=EPODOC&CC=PE&NR=20011326A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20020206&DB=EPODOC&CC=PE&NR=20011326A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GAO PING</creatorcontrib><creatorcontrib>FORBES JAMES C</creatorcontrib><creatorcontrib>HASSAN FRED</creatorcontrib><creatorcontrib>KARIM AZIZ</creatorcontrib><creatorcontrib>BRUGGER ANDREW M</creatorcontrib><title>EL USO DE UNA COMPOSICION DE CELECOXIB PARA EL ALIVIO RAPIDO DEL DOLOR</title><description>SE REFIERE AL USO DE CELECOXIB POR VIA ORAL UTILIZANDOSE DE 50mg A 400mg; EN AYUNAS PROPORCIONA UNA CONCENTRACION EN EL PLASMA DE AL MENOS 250 ng/ml A MAS TARDAR 30 MINUTOS DESPUES DE LA ADMINISTRACION O EXHIBE UN Tmax NO MAYOR DE 1.25 HORAS; EL CELECOXIB SE FORMULA COMO UNA DISPERSION ULTRA FINA O SOLUCION EN UN MEDIO LIQUIDO O SE FORMULA COMO PARTICULAS SOLIDAS QUE TIENEN UN TAMANO D90 MENOR DE 10µm; O SE FORMULA DISOLVIENDOLO EN UN SOLVENTE ADECUADO Y AGREGANDO LA SOLUCION RESULTANTE A UN LIQUIDO ACUOSO (POLIETILENGLICOL) PARA FORMAR UNA SUSPENSION FINA QUE SE ADMINISTRA AL INDIVIDUO A MAS TARDAR 15 MINUTOS DESPUES DE LA PREPARACION. LA FORMULACION SE ENCAPSULA CON UNA PARED QUE COMPRENDE GELATINA, HIDROXIPROPILMETILCELULOSA. TAMBIEN SE REFIERE AL USO EN COMBINACION CON CODEINA, MEPERIDINA, MORFINA, CAFEINA, TEOFILINA, TEOBROMINA.
There is provided a method of rapidly relieving pain in a mammalian, preferably human, subject. The method comprises orally administering to the subject an effective pain-relieving amount of a composition comprising celecoxib formulated in such a way as to provide, when tested in fasting humans in accordance with standard pharmacokinetic practice, a blood plasma concentration profile of celecoxib in which a concentration of about 250 ng/ml is attained not later than about 30 minutes after oral administration.</description><subject>BABY COMFORTERS</subject><subject>CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICALPURPOSES</subject><subject>DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY</subject><subject>DEVICES FOR RECEIVING SPITTLE</subject><subject>DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGINGPHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL ORADMINISTERING FORMS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2002</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHBz9VEIDfZXcHFVCPVzVHD29w3wD_Z09vT3Awk5u_q4OvtHeDopBDgGOSoA1Tr6eIZ5-isEOQZ4uoB0-Si4-Pv4B_EwsKYl5hSn8kJpbgZFN9cQZw_d1IL8-NTigsTk1LzUkvgAVyMDA0NDYyMzR0NjYtQAAEt8K3E</recordid><startdate>20020206</startdate><enddate>20020206</enddate><creator>GAO PING</creator><creator>FORBES JAMES C</creator><creator>HASSAN FRED</creator><creator>KARIM AZIZ</creator><creator>BRUGGER ANDREW M</creator><scope>EVB</scope></search><sort><creationdate>20020206</creationdate><title>EL USO DE UNA COMPOSICION DE CELECOXIB PARA EL ALIVIO RAPIDO DEL DOLOR</title><author>GAO PING ; FORBES JAMES C ; HASSAN FRED ; KARIM AZIZ ; BRUGGER ANDREW M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PE20011326A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2002</creationdate><topic>BABY COMFORTERS</topic><topic>CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICALPURPOSES</topic><topic>DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY</topic><topic>DEVICES FOR RECEIVING SPITTLE</topic><topic>DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGINGPHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL ORADMINISTERING FORMS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>GAO PING</creatorcontrib><creatorcontrib>FORBES JAMES C</creatorcontrib><creatorcontrib>HASSAN FRED</creatorcontrib><creatorcontrib>KARIM AZIZ</creatorcontrib><creatorcontrib>BRUGGER ANDREW M</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GAO PING</au><au>FORBES JAMES C</au><au>HASSAN FRED</au><au>KARIM AZIZ</au><au>BRUGGER ANDREW M</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>EL USO DE UNA COMPOSICION DE CELECOXIB PARA EL ALIVIO RAPIDO DEL DOLOR</title><date>2002-02-06</date><risdate>2002</risdate><abstract>SE REFIERE AL USO DE CELECOXIB POR VIA ORAL UTILIZANDOSE DE 50mg A 400mg; EN AYUNAS PROPORCIONA UNA CONCENTRACION EN EL PLASMA DE AL MENOS 250 ng/ml A MAS TARDAR 30 MINUTOS DESPUES DE LA ADMINISTRACION O EXHIBE UN Tmax NO MAYOR DE 1.25 HORAS; EL CELECOXIB SE FORMULA COMO UNA DISPERSION ULTRA FINA O SOLUCION EN UN MEDIO LIQUIDO O SE FORMULA COMO PARTICULAS SOLIDAS QUE TIENEN UN TAMANO D90 MENOR DE 10µm; O SE FORMULA DISOLVIENDOLO EN UN SOLVENTE ADECUADO Y AGREGANDO LA SOLUCION RESULTANTE A UN LIQUIDO ACUOSO (POLIETILENGLICOL) PARA FORMAR UNA SUSPENSION FINA QUE SE ADMINISTRA AL INDIVIDUO A MAS TARDAR 15 MINUTOS DESPUES DE LA PREPARACION. LA FORMULACION SE ENCAPSULA CON UNA PARED QUE COMPRENDE GELATINA, HIDROXIPROPILMETILCELULOSA. TAMBIEN SE REFIERE AL USO EN COMBINACION CON CODEINA, MEPERIDINA, MORFINA, CAFEINA, TEOFILINA, TEOBROMINA.
There is provided a method of rapidly relieving pain in a mammalian, preferably human, subject. The method comprises orally administering to the subject an effective pain-relieving amount of a composition comprising celecoxib formulated in such a way as to provide, when tested in fasting humans in accordance with standard pharmacokinetic practice, a blood plasma concentration profile of celecoxib in which a concentration of about 250 ng/ml is attained not later than about 30 minutes after oral administration.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | spa |
| recordid | cdi_epo_espacenet_PE20011326A1 |
| source | esp@cenet |
| subjects | BABY COMFORTERS CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICALPURPOSES DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY DEVICES FOR RECEIVING SPITTLE DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGINGPHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL ORADMINISTERING FORMS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | EL USO DE UNA COMPOSICION DE CELECOXIB PARA EL ALIVIO RAPIDO DEL DOLOR |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T04%3A14%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GAO%20PING&rft.date=2002-02-06&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPE20011326A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |